Google
IART 株価分析 — INTEGRA LIFESCIENCES HOLDINGS (Healthcare >> Medical Devices)
IART に関するよくある質問
IARTのPER（株価収益率）は？
INTEGRA LIFESCIENCES HOLDINGS（IART）は現在PER 479.29倍で取引されています。
IARTのROE（自己資本利益率）は？
INTEGRA LIFESCIENCES HOLDINGSのROEは-0.69%です。
IARTの配当利回りは？
INTEGRA LIFESCIENCES HOLDINGSの配当利回りは0.00%です。
IARTの品質スコア（Quality Score）は？
当社のAIはIARTの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
IARTは今が買い時ですか？
当社AIのタイミングスコアは100点中69点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
IARTはどのセクターに属しますか？
INTEGRA LIFESCIENCES HOLDINGSはHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）
IART AI Analysis Summary
Our AI summary for IART: INTEGRA LIFESCIENCES HOLDINGS (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 479.29, ROE of -0.69%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 69/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 16.65
Price
-0.47
(-2.75%)
Day Change
|
|
|---|
IART, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 16.65 |
| PBV / Sector |
1.27 / -101.57
GOOD
|
| Earning Per Share | -0.09 |
| PE / Sector |
479.29 / 31.23
|
| PEG or PE/Growth / Sector |
0.20 / 0.40
GREAT
|
| Average 1M Daily Value |
18.58 M
GREAT
|
| Average 1W Daily Value |
25.74 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:59 |
| Symbol | IART |
| Name | INTEGRA LIFESCIENCES HOLDINGS |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 77.77 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,331.47 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1100 Campus Road, Princeton, NJ, United States, 08540
Phone: 609 275 0500
Website: https://www.integralife.com
Employees: 4,427
Sector: Healthcare >> Medical Devices
Description: Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
